Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135719 · ClinicalTrials.gov registry record · NA
A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser
A NA study, sponsored by Edward E. Manche.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT01135719 is a NA study that has completed, run by Edward E. Manche. The registered enrollment target is 137 participants.
The verdict
NCT01135719, a NA study, has completed, sponsored by Edward E. Manche.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized excimer laser.
Interventions
- PROCEDURE LASIK and PRK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2009-04 |
| Est. Completion | 2022-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01135719
The ClinicalTrials.gov registry entry for NCT01135719 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edward E. Manche, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LASIK and PRK is the first listed.
NCT01135719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01135719 about?
NCT01135719 is a clinical study titled "A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser". Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized excimer laser.
What is the current status of trial NCT01135719?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2009-04. Estimated completion is 2022-12-03.
What interventions are being tested in trial NCT01135719?
The interventions under investigation include: LASIK and PRK (PROCEDURE).
Who is sponsoring clinical trial NCT01135719?
This trial is sponsored by Edward E. Manche, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.